Pfizer has sold 700 million shares in British consumer- healthcare business Haleon for £2.5 billion, equivalent to US$3.05 billion.
This story is from the January 16, 2025 edition of The Wall Street Journal.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the January 16, 2025 edition of The Wall Street Journal.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In